TRIlogy-4

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

JNJ-79635322OngoingRecruitingPhase 3Open NCT07258511 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

TRIlogy-4 · Trial Tracker · ComplyRx